BACKGROUND: Heart failure is a common complication after myocardial infarction (MI) and is associated with increased mortality. Whether remote heart failure symptoms assessment after MI can improve risk stratification is unknown. The authors evaluated the association of the 23-item Kansas City Cardiomyopathy Questionnaire (KCCQ) with all-cause mortality after MI. METHODS AND RESULTS: Prospectively collected data from consecutive patients hospitalized for MI at a large tertiary heart center between June 2017 and September 2022 were used. Patients remotely completed the KCCQ 1 month after discharge. A total of 1135 (aged 64±12 years, 26.7% women) of 1721 eligible patients completed the KCCQ. Ranges of KCCQ scores revealed that 30 (2.6%), 114 (10.0%), 274 (24.1%), and 717 (63.2%) had scores <25, 25 to 49, 50 to 74, and ≥75, respectively. During a mean follow-up of 46 months (interquartile range, 29-61), 146 (12.9%) died. In a fully adjusted analysis, KCCQ scores <50 were independently associated with mortality (hazard ratio [HR], 6.05 for KCCQ <25, HR, 2.66 for KCCQ 25-49 versus KCCQ ≥50; both P<0.001). Adding the 30-day KCCQ to clinical risk factors improved risk stratification: change in area under the curve of 2.6 (95% CI, 0.3-5.0), Brier score of -0.6 (95% CI, -1.0 to -0.2), and net reclassification improvement of 0.71 (95% CI, 0.45-1.04). KCCQ items most strongly associated with mortality were walking impairment, leg swelling, and change in symptoms. CONCLUSIONS: Remote evaluation of heart failure symptoms using the KCCQ among patients recently discharged for MI identifies patients at risk for mortality. Whether closer follow-up and targeted therapy can reduce mortality in high-risk patients warrants further study.

1st Medical School Charles University Prague Czech Republic

3rd Medical School Charles University Prague Czech Republic

Department of Cardiology Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Preventive Cardiology Institute for Clinical and Experimental Medicine Prague Czech Republic

Experimental Medicine Centre Institute for Clinical and Experimental Medicine Prague Czech Republic

Medical and Dentistry School Palacký University Olomouc Czech Republic

University of Missouri Kansas City's Healthcare Institute for Innovations in Quality and Saint Luke's Mid America Heart Institute Kansas City MO USA

University of Utah School of Medicine Salt Lake City UT USA

Zobrazit více v PubMed

Wohlfahrt P, Stehlik J, Pan IZ, Ryan JJ. Empowering people living with heart failure. Heart Fail Clin. 2020;16:409–420. doi: 10.1016/j.hfc.2020.06.002 PubMed DOI

Calkins DR, Rubenstein LV, Cleary PD, Davies AR, Jette AM, Fink A, Kosecoff J, Young RT, Brook RH, Delbanco TL. Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med. 1991;114:451–454. doi: 10.7326/0003-4819-114-6-451 PubMed DOI

Rumsfeld JS, Alexander KP, Goff DC, Graham MM, Ho PM, Masoudi FA, Moser DK, Roger VL, Slaughter MS, Smolderen KG, et al. Cardiovascular health: the importance of measuring patient‐reported health status. Circulation. 2013;127:2233–2249. doi: 10.1161/CIR.0b013e3182949a2e PubMed DOI

Heidenreich PA, Spertus JA, Jones PG, Weintraub WS, Rumsfeld JS, Rathore SS, Peterson ED, Masoudi FA, Krumholz HM, Havranek EP, et al. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol. 2006;47:752–756. doi: 10.1016/j.jacc.2005.11.021 PubMed DOI

Pokharel Y, Khariton Y, Tang Y, Nassif ME, Chan PS, Arnold SV, Jones PG, Spertus JA. Association of serial Kansas City Cardiomyopathy Questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection fraction: a secondary analysis of 2 randomized clinical trials. JAMA Cardiol. 2017;2:1315–1321. doi: 10.1001/jamacardio.2017.3983 PubMed DOI PMC

Mishra RK, Yang W, Roy J, Anderson AH, Bansal N, Chen J, DeFilippi C, Delafontaine P, Feldman HI, Kallem R, et al. Kansas City Cardiomyopathy Questionnaire score is associated with incident heart failure hospitalization in patients with chronic kidney disease without previously diagnosed heart failure. Circ: Heart Fail. 2015;8:702–708. doi: 10.1161/CIRCHEARTFAILURE.115.002097 PubMed DOI PMC

Hu D, Liu J, Zhang L, Bai X, Tian A, Huang X, Zhou K, Gao M, Ji R, Miao F, et al. Health status predicts short‐ and long‐term risk of composite clinical outcomes in acute heart failure. JACC: Heart Failure. 2021;9:861–873. doi: 10.1016/j.jchf.2021.06.015 PubMed DOI

Parissis JT, Nikolaou M, Farmakis D, Paraskevaidis IA, Bistola V, Venetsanou K, Katsaras D, Filippatos G, Kremastinos DT. Self‐assessment of health status is associated with inflammatory activation and predicts long‐term outcomes in chronic heart failure. Eur J Heart Fail. 2009;11:163–169. doi: 10.1093/eurjhf/hfn032 PubMed DOI PMC

Soto GE, Jones P, Weintraub WS, Krumholz HM, Spertus JA. Prognostic value of health status in patients with heart failure after acute myocardial infarction. Circulation. 2004;110:546–551. doi: 10.1161/01.CIR.0000136991.85540.A9 PubMed DOI

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan G‐A, Dweck MR, Galbraith M, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: developed by the Task Force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2023;44:3720–3826. doi: 10.1093/eurheartj/ehad191 PubMed DOI

Aragam KG, Tamhane UU, Kline‐Rogers E, Li J, Fox KA, Goodman SG, Eagle KA, Gurm HS. Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores. PLoS One. 2009;4:e7947. doi: 10.1371/journal.pone.0007947 PubMed DOI PMC

D'Ascenzo F, Biondi‐Zoccai G, Moretti C, Bollati M, Omedè P, Sciuto F, Presutti DG, Modena MG, Gasparini M, Reed MJ, et al. TIMI, GRACE and alternative risk scores in acute coronary syndromes: a meta‐analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp Clin Trials. 2012;33:507–514. doi: 10.1016/j.cct.2012.01.001 PubMed DOI

Fox KA, Fitzgerald G, Puymirat E, Huang W, Carruthers K, Simon T, Coste P, Monsegu J, Gabriel Steg P, Danchin N, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014;4:e004425. doi: 10.1136/bmjopen-2013-004425 PubMed DOI PMC

Jenča D, Melenovský V, Stehlik J, Staněk V, Kettner J, Kautzner J, Adámková V, Wohlfahrt P. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail. 2021;8:222–237. doi: 10.1002/ehf2.13144 PubMed DOI PMC

Gerber Y, Weston SA, Enriquez‐Sarano M, Berardi C, Chamberlain AM, Manemann SM, Jiang R, Dunlay SM, Roger VL. Mortality associated with heart failure after myocardial infarction: a contemporary community perspective. Circ Heart Fail. 2016;9:e002460. doi: 10.1161/CIRCHEARTFAILURE.115.002460 PubMed DOI PMC

Wohlfahrt P, Jenča D, Melenovský V, Šramko M, Kotrč M, Želízko M, Mrázková J, Adámková V, Pitha J, Kautzner J. Trajectories and determinants of left ventricular ejection fraction after the first myocardial infarction in the current era of primary coronary interventions. Front Cardiovasc Med. 2022;9:1051995. doi: 10.3389/fcvm.2022.1051995 PubMed DOI PMC

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction . Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618–e651. doi: 10.1161/CIR.0000000000000617 PubMed DOI

Spertus JA, Jones PG, Sandhu AT, Arnold SV. Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state‐of‐the‐art review. J Am Coll Cardiol. 2020;76:2379–2390. doi: 10.1016/j.jacc.2020.09.542 PubMed DOI

Kosiborod M, Soto GE, Jones PG, Krumholz HM, Weintraub WS, Deedwania P, Spertus JA. Identifying heart failure patients at high risk for near‐term cardiovascular events with serial health status assessments. Circulation. 2007;115:1975–1981. doi: 10.1161/CIRCULATIONAHA.106.670901 PubMed DOI

Dunlay SM, Gheorghiade M, Reid KJ, Allen LA, Chan PS, Hauptman PJ, Zannad F, Maggioni AP, Swedberg K, Konstam MA, et al. Critical elements of clinical follow‐up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail. 2010;12:367–374. doi: 10.1093/eurjhf/hfq019 PubMed DOI PMC

Wohlfahrt P, Jenča D, Stehlik J, Melenovský V, Mrázková J, Staněk V, Kettner J, Šramko M, Želízko M, Adámková V, et al. Heart failure‐related quality‐of‐life impairment after myocardial infarction. Clin Res Cardiol. 2023;112:39–48. doi: 10.1007/s00392-022-02008-z PubMed DOI

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli‐Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST‐segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST‐segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177. doi: 10.1093/eurheartj/ehx393 PubMed DOI

Sulo G, Igland J, Vollset SE, Nygård O, Ebbing M, Sulo E, Egeland GM, Tell GS. Heart failure complicating acute myocardial infarction; burden and timing of occurrence: a nation‐wide analysis including 86 771 patients from the Cardiovascular Disease in Norway (CVDNOR) project. J Am Heart Assoc. 2016;5:e002667. doi: 10.1161/JAHA.115.002667 PubMed DOI PMC

Fanaroff AC, Roe MT, Clare RM, Lokhnygina Y, Navar AM, Giugliano RP, Wiviott SD, Tershakovec AM, Braunwald E, Blazing MA. Competing risks of cardiovascular versus noncardiovascular death during long‐term follow‐up after acute coronary syndromes. J Am Heart Assoc. 2017;6:e005840. doi: 10.1161/JAHA.117.005840 PubMed DOI PMC